Immunoassay Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits (ELISA Reagents & Kits, Rapid Test Reagent & Kits, ELISpot Reagent & Kits, Western Blot Reagent & Kits), By Technology(ELISA, Rapid Tests, ELISpot, Western Blotting), By Specimen(Blood, Saliva, Urine, Other Specimens), By Application(Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders), By End User(Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2054 | Region: Global | Published Date: July, 2024
Pages: 242 |Tables: 164 |Figures: 78

Immunoassay Market Insights

Immunoassay Market size was valued at USD 29.72 billion in 2021 and is poised to grow from USD 30.02 billion in 2022 to USD 45.1 billion by 2030, growing at a CAGR of 5.32% in the forecast period (2023-2030).

Immunoassay is a bioanalytical technique that uses antigen-antibody affinity to differentiate and measure molecules of interest in biological samples. Immunoassays are laboratory procedures that can identify particular compounds quickly and precisely. Increased R&D efforts, as well as an increase in disease diagnostics, cancer markers, cardiac analysis, therapeutic medication monitoring, and clinical research techniques, are likely to boost market growth. In hospitals and medical laboratories, immunoassays can be used to perform automated biochemical exams to detect the presence and concentration of certain compounds in samples. Immunoassays' roles in numerous bioanalytical applications such as medical diagnostics, environmental monitoring, biopharmaceutical analysis, and food testing are driving market expansion.

US Immunoassay Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 29.72 billion

Largest Segment

Reagents and kits

Fastest Growth

Reagents and kits

Growth Rate

5.32% CAGR

Global Immunoassay Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Immunoassay Market Segmental Analysis

Global Immunoassay market is segmented based on product type, technology, specimen, application, end user, region. Based on the product type, the Immunoassay Market is segmented into Reagents & Kits (ELISA Reagents & Kits, Rapid Test Reagent & Kits, ELISpot Reagent & Kits, Western Blot Reagent & Kits, Other Reagent & Kits) Analyzers (Type (Open-ended Systems, Closed-ended Systems), (Purchase Mode (Rental Purchase, Outright Purchase)). Based on technology, the Immunoassay Market is segmented into ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassays, and Other Technologies. Based on the specimen, the Immunoassay Market is segmented into blood, saliva, urine, other specimens. Based on application, the Immunoassay Market is segmented into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, other applications. Based on the end user, the Immunoassay Market is segmented into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies and CROS, blood banks, research & academic laboratories, home care settings. Based on the region Immunoassay Market is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Immunoassay Market Analysis by Technology

In 2022, the EIA/ELISA category dominated the immunoassay market. The advantages of this approach over immune-electrophoresis and immunodiffusion are shorter testing times, quantitative results, and the use of less antisera for analysis. A rapid test, also known as a lateral flow immunoassay, detects the presence of a target analyte without the use of specialist equipment. The quick test technique has a variety of applications, including dengue and Legionella, Salmonella, Campylobacter, Zika, and Listeria diseases. Furthermore, monoclonal antibodies are used specifically for Immunoglobulin G (IgG), Immunoglobulin M (IgM), Immunoglobulin A (IgA), and Immunoglobulin (IgD) for precise identification of target analyte.

Global Immunoassay Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Immunoassay Market Regional Insights

In 2022, North America is expected to have the biggest share of the market. North America is expected to hold the highest share of the market and will continue to do so during the forecast period due to rising demand for technologically advanced products. Furthermore, increased R&D grants from the government and business health care organisations are advancing technology and supporting industry expansion. However, the Asia Pacific immunoassay market is predicted to grow at the fastest rate due to an increase in the incidence of infectious diseases, higher biotechnological research efforts, and an increase in the region's healthcare expenditure. During the projected period, Latin America, the Middle East, and Africa are expected to increase.

Further, due to presence of huge geriatric population and high frequency of infectious diseases, Asia Pacific is anticipated to increase at the fastest rate during the projection period. One of the reasons propelling the market in the area is the expanding usage of cutting-edge laboratory techniques and processes for quicker investigation and diagnosis of infectious and chronic illnesses. In addition, the development of molecular kits and the rise in demand for diagnostic reagents are major market drivers.

Global Immunoassay Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunoassay Market Dynamics

Immunoassay Market Driver

  • The prevalence of chronic diseases, combined with the high rate of infection and the COVID-19 pandemic, has demanded the adoption of immune-diagnostic assays for containment and management. Immunoassay tests are regarded as a critical diagnostic tool because they provide reliable and low-cost identification of infections or target compounds. These tests are used to identify both acute and chronic illnesses. Immunoassays have become the gold standard for detecting a variety of infections and pathophysiological states on a global scale. Another key factor driving market expansion is the increased demand for early-stage diagnosis of illness conditions employing immunoassay products.
  • Globally, there will be 783 million diabetics by 2045, up from 643 million in 2030. In 2021, diabetes caused 6.7 million deaths worldwide, and 541 million people are thought to be at risk of having the disease (Source: International Diabetes Federation). The WHO emphasized the HIV epidemic's worldwide significance, which has resulted in over 33 million deaths and an estimated 38 million HIV infections. Similar estimates of 19.3 million new cases of cancer and 10.0 million fatalities from the disease were made by GLOBOCAN and the International Agency for Research on Cancer. With 2.3 million new cases, breast cancer leads this estimate, followed by lung, colorectal, prostate, and stomach cancer. Hence, this creates a wide scope for the market growth.

Immunoassay Market Restraint

  • The use of immunoassays has a number of drawbacks. Cross-reactivity has consistently presented a problem for the immunoassays' dependability and specificity. In immunoassays, antibodies bind to structural analogues of the target antibody/analyte. High sample volume requirements for detection, complicated procedures, unsuitability for high-throughput screening analysis (ELISA), and reagent instability are further problems. Low-concentration analytes or target molecules are not thought to be acceptable for the standard colorimetric readout ELISA. In order to identify viral RNA sequences, immunoassays are not thought of as precise tests. They have been reported to have problems recognising specific biomolecules including interferons, rheumatoid factor, and non-specific IgM. During the early stages of an illness, immunoassays are also associated with false negatives. This erroneous sensitivity poses a barrier for those who are slightly symptomatic to asymptomatic and have a low antibody titer in response to coronavirus infection.

Request Free Customization of this report to help us to meet your business objectives.

Immunoassay Market Competitive Landscape

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Immunoassay Market Top Players Company Profiles

  • Abbott Laboratories
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Merck KGaA
  • Sysmex Corporation
  • PerkinElmer Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics, Inc.
  • Beckman Coulter, Inc.
  • Grifols, S.A.
  • Tosoh Corporation

Immunoassay Market Recent Developments

  • In June 2022, Roche received Emergency Use Authorization from the FDA for the Cobas SARS-CoV- 2 Duo for use on the fully automated Cobas 6800/8800 Systems.
  • In September 2021, Thermo Fisher Scientific, Inc. (US) introduced its fully automated analyzers, Thermo Scientific Gallery Enzyme Master and Thermo Scientific Gallery Plus Enzyme Master, which are precisely designed for enzyme assay applications.
  • In May 2021, Beckman Coulter (US) introduced its fully automated and qualitative COVID-19 immunoassay, Access SARS-CoV-2 IgG (1st IS). The immunoassay is a fully quantitative lab-based Immunoglobulin G (IgG) serology test intended to measure the number of antibodies against the virus that causes COVID-19.
  • In February 2021, F. Hoffmann-La Roche (Switzerland) introduced the SARS-CoV-2 Rapid Antigen Test Nasal with patient self-collection.

Immunoassay Key Market Trends

  • Major factors driving market expansion include an increase in occurrences and the prevalence of infectious diseases. According to the World Health Organization (WHO), over 30 novel diseases have emerged in the previous two decades, threatening the health of millions of people. Furthermore, the WHO estimates that 7% of hospitalized patients in industrialized countries and 10% of hospitalized patients in poor countries will contract at least one health-related infection. As a result, the increased number of patients with infectious disorders is expected to drive up demand for immunoassay devices globally.

Immunoassay Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, Global Immunoassay market is segmented based on product type, technology, specimen, application, end user, region. Based on the product type, Reagents & Kits held the most significant market share. Based on the specimen, blood held the most significant market share. Based on application, infectious diseases held the most significant market share. Based on the end user, hospitals & clinics held the most significant market share. Based on the region, North America held the most significant market share.

Report Metric Details
Market size value in 2023 USD 29.72 billion
Market size value in 2031 USD 45.1 billion
Growth Rate 5.32%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Reagents & Kits (ELISA Reagents & Kits, Rapid Test Reagent & Kits, ELISpot Reagent & Kits, Western Blot Reagent & Kits, Other Reagent & Kits) Analyzers (Type (Open-ended Systems, Closed-ended Systems), (Purchase Mode (Rental Purchase, Outright Purchase))
  • Technology
    • ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassays, and Other Technologies
  • Specimen
    • Blood, Saliva, Urine, Other Specimens
  • Application
    • Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Other Applications
  • End User
    • Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories, Home Care Settings
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Merck KGaA
  • Sysmex Corporation
  • PerkinElmer Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics, Inc.
  • Beckman Coulter, Inc.
  • Grifols, S.A.
  • Tosoh Corporation
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunoassay Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunoassay Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunoassay Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunoassay Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunoassay Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunoassay Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunoassay Market size was valued at USD 29.72 billion in 2021 and is poised to grow from USD 30.02 billion in 2022 to USD 45.1 billion by 2030, growing at a CAGR of 5.32% in the forecast period (2023-2030).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Abbott Laboratories', 'Danaher Corporation', 'Roche Diagnostics', 'Siemens Healthineers', 'bioMérieux SA', 'Bio-Rad Laboratories, Inc.', 'DiaSorin S.p.A.', 'Becton, Dickinson and Company', 'Thermo Fisher Scientific Inc.', 'Quidel Corporation', 'Merck KGaA', 'Sysmex Corporation', 'PerkinElmer Inc.', 'Ortho-Clinical Diagnostics, Inc.', 'Luminex Corporation', 'Randox Laboratories Ltd.', 'Fujirebio Diagnostics, Inc.', 'Beckman Coulter, Inc.', 'Grifols, S.A.', 'Tosoh Corporation'

The prevalence of chronic diseases, combined with the high rate of infection and the COVID-19 pandemic, has demanded the adoption of immune-diagnostic assays for containment and management. Immunoassay tests are regarded as a critical diagnostic tool because they provide reliable and low-cost identification of infections or target compounds. These tests are used to identify both acute and chronic illnesses. Immunoassays have become the gold standard for detecting a variety of infections and pathophysiological states on a scale. Another key factor driving market expansion is the increased demand for early-stage diagnosis of illness conditions employing immunoassay products.

Major factors driving market expansion include an increase in occurrences and the prevalence of infectious diseases. According to the World Health Organization (WHO), over 30 novel diseases have emerged in the previous two decades, threatening the health of millions of people. Furthermore, the WHO estimates that 7% of hospitalized patients in industrialized countries and 10% of hospitalized patients in poor countries will contract at least one health-related infection. As a result, the increased number of patients with infectious disorders is expected to drive up demand for immunoassay devices globally.

In 2022, North America is expected to have the biggest share of the market. North America is expected to hold the highest share of the market and will continue to do so during the forecast period due to rising demand for technologically advanced products. Furthermore, increased R&D grants from the government and business health care organisations are advancing technology and supporting industry expansion. However, the Asia Pacific immunoassay market is predicted to grow at the fastest rate due to an increase in the incidence of infectious diseases, higher biotechnological research efforts, and an increase in the region's healthcare expenditure. During the projected period, Latin America, the Middle East, and Africa are expected to increase.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2054

$5,300
BUY NOW GET FREE SAMPLE